GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Zitonggong Pharmaceutical Co Ltd (BJSE:832566) » Definitions » 3-Year Book Growth Rate

Sichuan Zitonggong Pharmaceutical Co (BJSE:832566) 3-Year Book Growth Rate : 15.30% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sichuan Zitonggong Pharmaceutical Co 3-Year Book Growth Rate?

Sichuan Zitonggong Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥5.23.

During the past 12 months, Sichuan Zitonggong Pharmaceutical Co's average Book Value per Share Growth Rate was 5.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was 15.30% per year. During the past 5 years, the average Book Value per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Sichuan Zitonggong Pharmaceutical Co was 17.00% per year. The lowest was 9.40% per year. And the median was 12.40% per year.


Competitive Comparison of Sichuan Zitonggong Pharmaceutical Co's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Zitonggong Pharmaceutical Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Zitonggong Pharmaceutical Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Zitonggong Pharmaceutical Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Sichuan Zitonggong Pharmaceutical Co's 3-Year Book Growth Rate falls into.



Sichuan Zitonggong Pharmaceutical Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Sichuan Zitonggong Pharmaceutical Co  (BJSE:832566) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Sichuan Zitonggong Pharmaceutical Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Sichuan Zitonggong Pharmaceutical Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Zitonggong Pharmaceutical Co (BJSE:832566) Business Description

Traded in Other Exchanges
N/A
Address
No. 456, Anji Street, Economic and Technological Development Zone, Sichuan Province, Neijiang, CHN, 641000
Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.

Sichuan Zitonggong Pharmaceutical Co (BJSE:832566) Headlines

No Headlines